Transform the human condition by building a scalable, affordable genomic sequencing ecosystem that will support research and diagnostics
Our mission is to transform research and diagnostics with an affordable, scalable genomic sequencing ecosystem.We believe in providing innovative sequencing solutions and high-quality service to our customers and partners. We lead with integrity and resiliency. We promise our stakeholders transparency, inclusivity and collaboration.It was founded in 2010 and headquartered in Redwood City, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 27, 2021 | Series D | $70M | 3 | Farallon Capital Management | — | Detail |
Feb 6, 2020 | Debt Financing | $75M | 1 | Oxford Finance LLC | — | Detail |
Nov 21, 2019 | Series C | $90M | 1 | Foresite Capital | — | Detail |
Jan 15, 2018 | Series C | $32.50M | 1 | — | — | Detail |
Mar 30, 2017 | Convertable Note | — | — | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Farallon Capital Management | Yes | Series D |
Oxford Finance LLC | Yes | Debt Financing |
Foresite Capital | Yes | Series C |
IPV Capital | Yes | Series B |
PBM Capital Group | — | Series D |
Soleus Capital | — | Series D |
Casdin Capital | — | Series C |
Decheng Capital | — | Series B |
National Human Genome Research Institute | — | Grant |
Plug and Play | — | Convertable Note |